Commense Bio

Commense Bio is a biopharmaceutical company committed to developing and delivering transformative therapeutics for patients suffering from invasive infections with a significant unmet need. Our proprietary technology has the potential to unlock the next generation of bacterial therapeutics. Commense Bio is utilizing differentiated synthetic biology to engineer optimized bacterial strains and deliver novel therapeutics. Our innovative Safety Switched ™ strains mimic nature and use bacterial interference to prevent invasive infections. At Commense Bio, we are applying our broad IP Platform across multiple infectious diseases as we strive to establish new, transformative standards of care.